Yuchen Hou
1630 Dongfang Road
Dongfang, 200127, China
Dongfang, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Epigenetic activation of VEGFA by SMARCD1 mediates tumor progression and bevacizumab resistance in clear cell renal cell carcinoma.
Journal: BMC cancer
Published: November 04, 2025
Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 14, 2025
Metabolomic and transcriptomic profiling of HNSCC identifies AMIGO2 as a therapeutic target modulating tumor microenvironment.
Journal: NPJ precision oncology
Published: January 20, 2025
Dual Oxygen-Supply Immunosuppression-Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid-Derived Suppressor Cells.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 08, 2024
Chromatin Helicase CHD6 Establishes Proinflammatory Enhancers and Is a Synthetic Lethal Target in FH-Deficient Renal Cell Carcinoma.
Journal: Cancer research
Published: March 08, 2024
GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism.
Journal: BioMed research international
Published: August 12, 2022
Mental health in children with living donor liver transplantation: a propensity score-matched analysis.
Journal: Child and adolescent psychiatry and mental health
Published: July 14, 2022
A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy.
Journal: Materials today. Bio
Published: March 18, 2022
Modified Dual Hepatic Vein Anastomosis in Pediatric Living-Donor Liver Transplantation Using Left Lateral Segment Grafts With Two Wide Orifices.
Journal: Frontiers in pediatrics
Published: March 26, 2021
Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.
Journal: Aging
Published: November 02, 2019
Author Correction: A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Journal: Scientific reports
Published: May 05, 2019
Last Updated: 09/26/2026